SecBot SecBot

LLY

ELI LILLY & Co
NYSE· Pharmaceutical Preparations· Inc. IN· CIK 0000059478 Biotech & Drug Discovery
$1,437.43 −6.07 (−0.42%)
Nov 16 4:00 PM ET · prev $1,443.50
Market cap
$1.3T
Mega cap
Consensus
Buy
86% Buy or better · 37 analysts
Median target
$1,570.00
+9% · range $940.00–1,700.00
1 year
+40.7%
from $1,021.70 · Nov 17
30 days
+14.4%
from $1,257.03
52-week range
$851.21–1,443.50
−0% from high · low Apr 29
Avg volume 20D
2.97M
shares / day
Short interest
7.21M
≈0.8% of shares · +3.6%
Days to cover
2.7
at average volume
Insider net
−$41.6M
0 buyers · 5 sellers · since Apr 20
New fund stakes
6
Q2 2026 13F · 2 exits
Reddit crowd
83°
Bullish · 11 mentions this week
SecBot read BULLISH 11 reports · 90 days
Balance 0 bearish · 3 bullish · 8 neutral oldest → newest, height = score
Avg score ·High conf. 9/11

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

  • Feb 9 to Feb 13 ▼ 2 sells: David Taylor, Angus King sold $1,001 - $15,000, last disclosed Mar 24
  • May 6 ▼ 1 insider sell $15.8M at $995.36
  • Jun 2 to Jun 10 ▲ 2 buys: Ro Khanna, Gilbert Cisneros bought, last disclosed Jul 8
  • Jun 10 ▼ 1 insider sell $2.9M at $1,150.77
  • Jun 30 ▲ 6 funds open new positions (13F)
  • Jul 1 to Jul 10 ▼ 2 sells: Michael Rulli, Dan Newhouse sold $1,001 - $15,000, last disclosed Aug 10
  • Jul 30 to Aug 7 3 court rulings: Eli Lilly and Company v. Empower Clinic Services, LLC; Eli Lilly And Company v. Revive RX, LLC and 1 more
  • Aug 5 ▲ Lilly reported Q2 2026 revenue of $22.97B (up 48% YoY, 11% above con…
  • Aug 7 to Aug 17 ▼ 3 days of insider sells: $16.0M by 3 insiders, avg $1,182.09
  • Aug 14 ▲ Short interest falls 28.0% to 6.56M
  • Oct 14 Trial readout: Results Pending: Orforglipron (Phase 3), Completed 85d ago
  • Nov 2 ▼ 1 insider sell $7.0M at $1,402.52
  • Nov 16 New catalyst: subscribers see the details Unlock

Signal stack

Where each data set points today.

  • InsidersBEARISH

    5 insiders sold $41.6M.

  • InstitutionsMIXED

    Q2 2026: 55 added (6 new), 38 trimmed or exited. Largest new: Castle Hook Partners $558.0M, Meitav Investment House $143.1M.

  • AnalystsBULLISH

    32 of 37 rate it Buy or better. Median target $1,570.00 (+9%).

  • Short sellersSTEADY

    Short interest +3.6% to 7.21M shares. 2.7 days to cover, ≈0.8% of shares.

  • TrendUPTREND

    15% above its 50-day average. New closing high $1,443.50 on Nov 13.

  • SocialQUIET

    Crowd 83° (bullish) this week from 11 mentions: 10 bullish, 0 bearish. No setup is alerting. Excludes 1 subscriber-only day.

Who's buying

13F· Q2 2026
6
new positions
2
exits
$701.1M
in new stakes · top 2 shown
FundMoveSharesValue
AMERICAN CENTURY COMPANIES INCADD2,354,837$2.8B
BARCLAYS PLCTRIM1,143,891$1.4B
CITADEL ADVISORS LLCDOUBLED945,456$1.1B
POLEN CAPITAL MANAGEMENT LLCTRIM666,912$799.9M
Quantinno Capital Management LPADD547,546$656.7M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.DOUBLED526,202$631.1M
PARNASSUS INVESTMENTS, LLCTRIM525,464$630.3M
Assenagon Asset Management S.A.TRIM501,025$600.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

37 analysts
Buy 86% rate it Buy or better
Strong Buy11Buy21Hold4Sell1Strong Sell0
12-month targets · 29 analysts

Price is inside the target range. Median implies +9%.Targets as of Nov 16, 2026.

Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Nov 9, 2026Jefferies
MAINTAIN
MAINTAINBuy
Nov 2, 2026Cantor Fitzgerald
MAINTAIN
MAINTAINOverweight
Oct 30, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 30, 2026JP Morgan
MAINTAIN
MAINTAINOverweight
Oct 30, 2026Citigroup
MAINTAIN
MAINTAINBuy
Congressional trades
LLY trades disclosed by members of Congress, with disclosure delay.
11 members · 10 buys / 12 sells
DateMemberType AmountDisclosed
Nov 3, 2026 David TaylorRHouse Eli Lilly and Co SELL $1K–$15K Nov 12, 2026 +9d
Nov 3, 2026 David TaylorRHouse Eli Lilly and Co SELL $1K–$15K Nov 12, 2026 +9d
Oct 20, 2026 Gilbert CisnerosDHouse Eli Lilly and Co BUY $1K–$15K Nov 10, 2026 +21d
Sep 4, 2026 Ro KhannaDHouse Spouse account · Eli Lilly and Co BUY $1K–$15K Oct 7, 2026 +33d
Jul 10, 2026 Dan NewhouseRHouse Spouse account · Eli Lilly and Co SELL $1K–$15K Jul 17, 2026 +7d
Jul 1, 2026 Michael RulliRHouse Eli Lilly and Co SELL $1K–$15K Aug 7, 2026 +37d
Jun 10, 2026 Gilbert CisnerosDHouse Eli Lilly and Co BUY $50K–$100K Jul 2, 2026 +22d
Jun 2, 2026 Ro KhannaDHouse Child account · Eli Lilly and Co BUY $1K–$15K Jul 6, 2026 +34d
May 1, 2026 Ro KhannaDHouse Child account · Eli Lilly and Co SELL $1K–$15K Jun 9, 2026 +39d
Apr 8, 2026 Lizzie FletcherDHouse Eli Lilly and Co SELL $1K–$15K May 1, 2026 +23d

Insider ledger

Form 4
$0
bought · 0 insiders
$41.6M
sold · 5 insiders
DateInsiderTypeValue
Nov 10, 2026
Jonsson Patrik
EVP & President, LLY Int'l
Nov 10, 2026
GIFT704 sh
Nov 3, 2026
Ricks David A
President, Chair, and CEO
Nov 3, 2026
GIFT23,538 sh
Nov 2, 2026
Skovronsky Daniel
EVP, CS&PO & Pres. LRL
Nov 2, 2026
GIFT119 sh
Nov 2, 2026
Hakim Anat
EVP, GC & Secretary
Nov 2, 2026
SELL$7.0M
Nov 1, 2026
Dozier Eric
EVP, Chief People Officer
Nov 1, 2026
EXERCISE2,300 sh
Nov 1, 2026
Hernandez Edgardo
EVP & Pres., Mfg. Operations
Nov 1, 2026
TAX W/H$1.6M
Nov 1, 2026
Custer Kenneth L.
EVP & President, Card Met Hlth
Nov 1, 2026
TAX W/H$2.0M
Nov 1, 2026
Dozier Eric
EVP, Chief People Officer
Nov 1, 2026
TAX W/H$1.4M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent
Nov 15, 2026
Trial readout
🔒 Fresh data, subscribers only
Nov 15, 2026
Trial readout
🔒 Fresh data, subscribers only
Nov 12, 2026
Press release
Lilly breaks ground in Pennsylvania's Lehigh Valley on a $3.5 billion site to make next-generation obesity medicines, the latest of 10 new U.S. sites since 2020
Facility will manufacture injectable medicines, including retatrutide Site will create 850 high-wage jobs and 2,000 construction jobs INDIANAPOLIS…
Nov 8, 2026
Trial readout
T-90d Trial Readout: Abemaciclib (Phase 2)
Trial: A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following…
Nov 8, 2026
Trial readout
T-90d Trial Readout: Methylprednisolone (Phase 2)
Trial: Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) Sponsor: Prevail Therapeutics Phase: Phase 2 | Status…

Washington

Corporate Lobbying

127 lobbying filings and 11 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
7,213,927
shares short
+3.6%
vs prior settlement
2.7
days to cover
≈0.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 15, 2026 Clinical trial readout
🔒 Fresh data, subscribers only
Nov 10, 2026 Insider
Jonsson Patrik gifted 704 shares
EVP & President, LLY Int'l
Nov 3, 2026 Insider
Ricks David A gifted 23,538 shares
President, Chair, and CEO
Nov 3, 2026 Congress
David Taylor sell
$1,001 - $15,000 · House
Nov 3, 2026 Congress
David Taylor sell
$1,001 - $15,000 · House
Nov 2, 2026 Insider
Skovronsky Daniel gifted 119 shares
EVP, CS&PO & Pres. LRL
Oct 30, 2026 SEC
Lilly Endowment Inc., the company's largest shareholder with a $108.4B stake, filed a Form 144 notice of intent to…
144 · Impact 3/10
Oct 29, 2026 SEC
Lilly reported Q3 2026 revenue of $24.4B (+39% YoY) and non-GAAP EPS of $7.48 (+7% YoY), beating consensus estimates…
8-K · Impact 6/10
Reddit Mentions per day, 14 days
Crowd this week 83° Bullish 10 bullish · 0 bearish
Mentions, 7 days 11 0 in posts · 11 in comments
Recent posts
Recent comments
r/ValueInvesting20h ago
Fresh comment, for subscribers
r/stocks20h ago
Fresh comment, for subscribers
r/stocks20h ago
Fresh comment, for subscribers
r/ValueInvesting20h ago
Fresh comment, for subscribers
All social signals and their track records

SecBot reports

22 filings · 1 press release · 6 bullish · 1 bearish · 15 neutral
All LLY filing & press-release reports (23)